Target Name: CLASRP
NCBI ID: G11129
Review Report on CLASRP Target / Biomarker Content of Review Report on CLASRP Target / Biomarker
CLASRP
Other Name(s): CLK4 associating serine/arginine rich protein, transcript variant 1 | CLASR_HUMAN | CLK4 associating serine/arginine rich protein | SFRS16 | Clk4 associating SR-related protein | SWAP2 | Suppressor of white apricot homolog 2 | Suppressor of white-apricot homolog 2 | CLK4-associating serine/arginine rich protein | CLK4-associating serine/arginine rich protein (isoform 1) | Splicing factor, arginine/serine-rich 16 | CLASP | CLASRP variant 1 | suppressor of white apricot homolog 2 | splicing factor, arginine/serine-rich 16 (suppressor-of-white-apricot homolog, Drosophila) | Splicing factor, arginine/serine-rich 16 (suppressor-of-white-apricot homolog, Drosophila)

CLASRP: A Potential Drug Target and Biomarker for associating Serine/Arginine-rich Proteins

Introduction

Serine and arginine are essential amino acids that play crucial roles in various cellular processes. As well-known nutrients, these amino acids have also been recognized as key regulators for protein synthesis and post-translational modifications, including modification of protein stability and localization. The CLASRP gene, located on chromosome 16, encodes a protein namedCLK4 associating serine/arginine-rich protein (CLASRP). In this article, we will explore the potential implications of CLASRP as a drug target and biomarker.

Potential Drug Target

The drug development process typically begins with the identification of potential therapeutic targets. In the case of CLASRP, its serine/argine-rich protein status makes it an attractive target for drug discovery. CLASRP has been shown to play a role in various cellular processes, including cell adhesion, migration, and invasion. Additionally, it has been linked to various diseases, including cancer and neurodegenerative disorders. Therefore, targeting CLASRP as a drug candidate could potentially lead to new treatments for a range of diseases.

Biomarker

As a potential biomarker, CLASRP can be used to diagnose and monitor disease progression. For example, the high expression of CLASRP has been observed in various cancer types, including breast, ovarian, and colorectal cancers. Therefore, measuring the level of CLASRP expression in cancer cells could be a promising diagnostic tool for these diseases. Additionally, the regulation of CLASRP has been shown to be associated with cancer cell survival and angiogenesis, which could make it a useful biomarker for monitoring cancer progression.

Expression and regulation

CLASRP is a 14-kDa protein that is expressed in various tissues and cells, including muscle, liver, and brain. It is primarily localized to the endoplasmic reticulum (ER) and cytoplasm, and can also be found in the secretion fraction of endoplasmic reticulum vesicles (ERVs). CLASRP has been shown to localize to the ERVs, where it can interact with various protein partners, including the protein kinase PDK4.

Additionally, CLASRP has been shown to be regulated by various intracellular signaling pathways, including TGF-β, NF-kappa-B, and PI3K/AKT. TGF-β signaling has been shown to play a role in the regulation of CLASRP expression, with reports indicating that TGF-β1 can induce CLASRP expression in various cell types.

Function and regulation

CLASRP is involved in various cellular processes, including cell adhesion, migration, and invasion. It has been shown to be involved in the regulation of cell-cell adhesion, as well as the formation of tight junctions in epithelial cells. Additionally, CLASRP has been shown to play a role in cell migration and invasion, as well as the regulation of angiogenesis.

CLASRP has also been shown to be involved in the regulation of various signaling pathways, including TGF-β, NF-kappa-B, and PI3K/AKT. TGF-β signaling has been shown to play a role in the regulation of CLASRP expression, with reports indicating that TGF-β1 can induce CLASRP expression in various cell types. NF-kappa-B signaling has also been shown to be involved in the regulation of CLASRP expression, with reports indicating that NF-kappa-B signaling can induce CLASRP expression in various cell types.

Conclusion

In conclusion, CLASRP is a protein that has been shown to play a role in various cellular processes, including cell adhesion, migration, and invasion. Its serine/argine-rich status makes it an attractive target for drug discovery, as well as a potential biomarker for disease diagnosis and monitoring. The regulation of CLASRP expression is involved in various signaling pathways, including TGF-β, NF-kappa-B, and PI3K/AKT. Further research is needed to fully understand the role of CLASRP in various cellular processes and its potential as a drug target and biomarker.

Protein Name: CLK4 Associating Serine/arginine Rich Protein

Functions: Probably functions as an alternative splicing regulator. May regulate the mRNA splicing of genes such as CLK1. May act by regulating members of the CLK kinase family (By similarity)

The "CLASRP Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CLASRP comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

Class III phosphatidylinositol 3-kinase (PI3-kinase) sub-complex | Clathrin | CLBA1 | CLC | CLCA1 | CLCA2 | CLCA3P | CLCA4 | CLCC1 | CLCF1 | CLCN1 | CLCN2 | CLCN3 | CLCN4 | CLCN5 | CLCN6 | CLCN7 | CLCNKA | CLCNKB | CLDN1 | CLDN10 | CLDN10-AS1 | CLDN11 | CLDN12 | CLDN14 | CLDN14-AS1 | CLDN15 | CLDN16 | CLDN17 | CLDN18 | CLDN19 | CLDN2 | CLDN20 | CLDN22 | CLDN23 | CLDN24 | CLDN25 | CLDN3 | CLDN34 | CLDN4 | CLDN5 | CLDN6 | CLDN7 | CLDN8 | CLDN9 | CLDND1 | CLDND2 | Cleavage and polyadenylation specificity factor complex | Cleavage factor Im complex | Cleavage Stimulation Factor | CLEC10A | CLEC11A | CLEC12A | CLEC12A-AS1 | CLEC12B | CLEC14A | CLEC16A | CLEC17A | CLEC18A | CLEC18B | CLEC18C | CLEC19A | CLEC1A | CLEC1B | CLEC2A | CLEC2B | CLEC2D | CLEC2L | CLEC3A | CLEC3B | CLEC4A | CLEC4C | CLEC4D | CLEC4E | CLEC4F | CLEC4G | CLEC4GP1 | CLEC4M | CLEC4OP | CLEC5A | CLEC6A | CLEC7A | CLEC9A | CLECL1P | CLGN | CLHC1 | CLIC1 | CLIC1P1 | CLIC2 | CLIC3 | CLIC4 | CLIC5 | CLIC6 | CLINT1 | CLIP1 | CLIP1-AS1 | CLIP2 | CLIP3 | CLIP4 | CLK1